The historical rank and industry rank for Elekta AB's EV-to-EBIT or its related term are showing as below:
OSTO:EKTA B'
s EV-to-EBIT Range Over the Past 10 Years
Min: 13.42 Med: 25.51 Max: 108.32
Current: 26.7
During the past 13 years, the highest EV-to-EBIT of Elekta AB was 108.32. The lowest was 13.42. And the median was 25.51.
OSTO:EKTA B's EV-to-EBIT is ranked worse than 62.09% of 459
companies
in the Medical Devices & Instruments industry
Industry Median: 20.67
vs OSTO:EKTA B: 26.70
The historical data trend for Elekta AB's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Elekta AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Elekta AB's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Elekta AB's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Elekta AB's EV-to-EBIT falls into.
Elekta AB's current Enterprise Value is kr22,799 Mil.
Elekta AB's EBIT for the trailing twelve months (TTM) ended in Apr. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr854 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Elekta AB (OSTO:EKTA B) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Elekta AB's Enterprise Value for the quarter that ended in Apr. 2025 was kr23,387 Mil.
Elekta AB's EBIT for the trailing twelve months (TTM) ended in Apr. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr854 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Elekta AB EV-to-EBIT Related Terms
Thank you for viewing the detailed overview of Elekta AB's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
Sweden-based Elekta develops, manufactures, and distributes treatment planning systems for neurosurgery and radiotherapy, including stereotactic radiosurgery and brachytherapy. The company has an installed base of more than 7,300 linear accelerators, Gamma Knife and Unity platforms, as well as brachytherapy installations. The company's sales are evenly distributed across geographies, with North and South America accounting for 30%; Europe, the Middle East, and Africa accounting for 36%; and the Asia-Pacific contributing the remainder.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
OSTO:EKTA B has been successfully added to your 